Nelson Peltz
Q2 2026 versus Q1 2026: 0 bought, 2 added to, 2 reduced, 0 sold. By dollars, the largest buy was GE HealthCare, $197.2M more at the quarter-end price; the largest sale Janus Henderson Group Plc, $323.1M less. Net, $161.2M more sold than bought. What every tracked investor did in Q2 2026.
Every move, largest first
| Ticker | Issuer | Move | Shares Q1 2026 → Q2 2026 | Bought / sold | Of the portfolio | Weight now | Price vs model |
|---|---|---|---|---|---|---|---|
| JHG | Janus Henderson Group PLC | reduced −19% | 31.9M → 25.7M | −$323.1M | −7.64% | 31.5% | — |
| GEHC | Ge Healthcare Technologies Inc. | added +76194% | 4,044 → 3.1M | +$197.2M | +4.66% | 4.7% | 40% undervalued |
| IVZ | Invesco Ltd. | reduced −45% | 3.0M → 1.6M | −$35.5M | −0.84% | 1.0% | no usable model value |
| WEN | Wendys Co. | added +0% | 30.4M → 30.5M | +$185,795.5 | +0.00% | 6.0% | — |
Bought / sold is the change in shares × the quarter's reported price (value ÷ shares in the filing); a position sold out is priced at the quarter before, since it has no price in this one. “Of the portfolio” is that amount against this quarter's reported book.
Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.